Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses

Area of Science:

• Biochemistry
• Immunology
• Materials Science

Background:

• Modified biopolymers derived from prebiotics are increasingly used in cancer treatment.
• Biomaterials and polymer-functionalized nanomaterials activate immune cells against tumors.
• Biological barriers limit immune cell effectiveness against cancer, necessitating enhanced host defenses.

Purpose of the Study:

• To highlight the immunomodulatory importance of inulin, a prebiotic.
• To review the development of inulin-based hybrid biopolymers.
• To discuss inulin's role in enhancing immunity and modifying cell surfaces for cancer treatment.

Main Methods:

• Review of scientific literature on prebiotic-based biopolymers and inulin.
• Analysis of chemical modification approaches for inulin.
• Exploration of inulin's application in cancer immunotherapy.

Main Results:

• Inulin significantly activates immune cells and promotes cytokine secretion.
• Modified inulin-based biopolymers show potential in cancer treatment.
• Chemical modifications of inulin can enhance its immunomodulatory properties.

Conclusions:

• Inulin-based biopolymers are crucial for enhancing host defense against cancer.
• Modified inulin holds significant promise for advancing cancer immunotherapy.
• Further research into chemically modified inulin can lead to novel cancer prevention strategies.